James Hamilton
Corporate Officer/Principal bei ARROWHEAD PHARMACEUTICALS, INC.
Vermögen: 6 Mio $ am 31.03.2024
Profil
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. (founded in 2005).
He is currently the Chief Discovery & Translational Medicine at Arrowhead Pharmaceuticals, Inc. He was formerly the Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton received his undergraduate degree from Miami University and his MBA and doctorate degrees from The Ohio State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.04.2024 | 204 851 ( 0,17% ) | 6 Mio $ | 31.03.2024 |
Aktive Positionen von James Hamilton
| Unternehmen | Position | Beginn |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| NanoValent Pharmaceuticals, Inc. | Founder | 23.02.2010 |
Ehemalige bekannte Positionen von James Hamilton
| Unternehmen | Position | Ende |
|---|---|---|
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | President | - |
Ausbildung von James Hamilton
| Miami University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
| NanoValent Pharmaceuticals, Inc. |
